Explore Stanford technologies available for licensing:

Stanford researchers have developed a new class of aryl ester RNA-reactive reagents that are stable for months in water yet rapidly modify RNA upon catalytic activation, enabling reliable, scalable tools for RNA research and therapeutic applications.

Stanford researchers have developed a method for screening RNA-modulating drugs that reports on changes to mRNA in its native cellular context.

Stanford scientists have developed a high throughput screening method to identify therapeutics known as translational activators to treat protein synthesis disorders and ribosomopathies.

There is broad potential to modulate RNA using small molecules, replacing more costly and difficult-to-administer oligonucleotide therapies. However, methods for screening for such small molecules are lacking.

A new deep-learning system called Atomic Rotationally Equivariant Scorer (ARES) significantly improves the prediction of RNA structures over previous artificial intelligence (AI) models.

Researchers in Dr. Mark Kay's lab have developed a patented approach to inducing apoptosis that could represent a new strategy against cancer and other diseases.

Stanford researchers in Professor Rhiju Das's lab have devised a method called RNAMake to optimize nucleic acids, such as aptamers and messenger RNAs, and enhance their effectiveness for clinical settings.